Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic Zocor(R) (RedNova)
Teva Pharmaceutical Industries Ltd. (Nasdaq: TE

Ranbaxy Receives FDA Approval To Market Simvastatin 80mg Tablets With 180-Day Exclusivity (Medical News Today)
Ranbaxy Pharmaceuticals Inc.(RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL),announced today that the company has received approval from the U.S. Foodand Drug Administration (FDA) to manufacture and market Simvastatin TabletsUSP, 80mg with 180-day exclusivity in the U.S. [click link for full article]